XML 55 R45.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Balance Sheet Details - Schedule of Accrued Expenses (Details) - USD ($)
$ in Thousands
Jun. 30, 2024
Dec. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]    
Other research and development $ 18,326 $ 30,759
Other accrued expenses 2,275 1,900
Clinical studies 1,552 2,156
Acquired manufacturing rights 0 25,000
Total $ 22,153 $ 59,815